Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2014 1
2015 3
2016 1
2018 3
2019 2
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Health and Racial Disparity in Breast Cancer.
Yedjou CG, Sims JN, Miele L, Noubissi F, Lowe L, Fonseca DD, Alo RA, Payton M, Tchounwou PB. Yedjou CG, et al. Among authors: sims jn. Adv Exp Med Biol. 2019;1152:31-49. doi: 10.1007/978-3-030-20301-6_3. Adv Exp Med Biol. 2019. PMID: 31456178 Free PMC article. Review.
Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 Axis.
Prete A, Lo AS, Sadow PM, Bhasin SS, Antonello ZA, Vodopivec DM, Ullas S, Sims JN, Clohessy J, Dvorak AM, Sciuto T, Bhasin M, Murphy-Ullrich JE, Lawler J, Karumanchi SA, Nucera C. Prete A, et al. Among authors: sims jn. Clin Cancer Res. 2018 Dec 1;24(23):6078-6097. doi: 10.1158/1078-0432.CCR-18-0693. Epub 2018 Aug 3. Clin Cancer Res. 2018. PMID: 30076136 Free PMC article.
Racial Disparities and Preventive Measures to Renal Cell Carcinoma.
Sims JN, Yedjou CG, Abugri D, Payton M, Turner T, Miele L, Tchounwou PB. Sims JN, et al. Int J Environ Res Public Health. 2018 May 28;15(6):1089. doi: 10.3390/ijerph15061089. Int J Environ Res Public Health. 2018. PMID: 29843394 Free PMC article.
Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model.
Duquette M, Sadow PM, Husain A, Sims JN, Antonello ZA, Fischer AH, Song C, Castellanos-Rizaldos E, Makrigiorgos GM, Kurebayashi J, Nose V, Van Hummelen P, Bronson RT, Vinco M, Giordano TJ, Dias-Santagata D, Pandolfi PP, Nucera C. Duquette M, et al. Among authors: sims jn. Oncotarget. 2015 Dec 15;6(40):42445-67. doi: 10.18632/oncotarget.6442. Oncotarget. 2015. PMID: 26636651 Free PMC article.
Thrombospondin-1-Based Antiangiogenic Therapy.
Sims JN, Lawler J. Sims JN, et al. J Ocul Pharmacol Ther. 2015 Sep;31(7):366-70. doi: 10.1089/jop.2015.0018. Epub 2015 Jun 3. J Ocul Pharmacol Ther. 2015. PMID: 26352160 Free PMC article.
13 results